Malaria remains the deadliest parasitic disease in the world despite years of sustained effort, new drug development, and a greater understanding of the causative parasite, Plasmodium, and its interactions with its host.

Malaria kills around 400,000 people each year and the prevention and treatment of this disease is highly reliant on chemotherapy.

Developing novel synthetic microbes for the sustainable production of biochemical, biofuels and bioplastics is critical for the emergence of a new global bioeconomy.

One of the most fundamental assumptions in biology is that the amino acid sequence defines protein structure and that this sequence carries no memory of the specific mRNA codon sequence from which it was translated.

Mitochondrial diseases (MDs) are the largest and most common group of inherited metabolic disorders. They comprise over 350 monogenic diseases and affect at least one child born each week in Australia.

Nutritional deficiencies are a leading cause of human susceptibility to infectious diseases and antibiotic treatment failure. Specifically, our intake of dietary lipids has changed dramatically, yet microbe-lipid interactions during infection are poorly understood.